Charah Solutions receives notification letter from NYSE

Charah Solutions received written notice from the New York Stock Exchange that the average closing price of its common stock over the prior consecutive 30 trading-day period was below $1.00 per share, which is the minimum average share price for continued listing on the NYSE. Charah Solutions intends to respond to the NYSE within ten business days of receipt of the notice with its intent to cure the deficiency. Pursuant to the NYSE’s rules, Charah Solutions has a six-month period following receipt of the deficiency letter to bring its closing share price and average closing share price back above $1.00. During the cure period, Charah Solutions’ shares of common stock will continue to trade on the NYSE, subject to compliance with other continued listing requirements. The NYSE notification does not affect Charah Solutions’ ongoing business operations or its Securities and Exchange Commission reporting requirements. Charah Solutions is considering all available options to regain compliance with the NYSE’s continued listing standards, including the consummation of the previously announced reverse stock split. As announced on December 28, 2022, Charah Solutions effected a one-for-ten reverse stock split of its common stock, par value $0.01 per share, effective at 5:00 p.m. Eastern Time on December 29, 2022. The reverse stock split, which was authorized by its Board of Directors, was approved by Charah Solutions’ stockholders on November 23, 2022. Upon market open on December 30, 2022, Charah Solutions’ common stock will continue trading under the symbol "CHRA" on a split-adjusted basis with a new CUSIP number: 15957P 303.